Leerink Partners analyst Mike Kratky maintained a Buy rating on Dexcom (DXCM – Research Report) on November 25 and set a price target of ...
Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are ...
Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for shares of DexCom in a note ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback